NAIROBI — Global pharmaceutical companies are ramping up a push for early cancer detection as a key step to enhance treatment of the disease across Africa. AstraZeneca, Chinese genomics firm BGI ...

Wits scientists have identified a "microbial watchlist" of bacteria, viruses, fungi and parasites that could cause cancer. Subscribe to our newsletter for the latest sci-tech news updates. Infections ...

For almost 44 years, Willie Bell never missed his appointment to check for prostate cancer. But then the pandemic hit. The doctor’s office was closed. Three months passed before he was able to be ...

Healthcare disparities exacerbate disease differences between African-Americans and their white counterparts, and with prostate cancer, it’s no different. According to The Washington Post, Black men ...

The moment you’re told the dreaded words: “You have cancer,” your life changes forever. A parent diagnosed with cancer goes through a rollercoaster of emotions from guilt and shame to resiliency. “For ...

Linda Nordling is a freelance writer in Cape Town, South Africa. It took Eve Namisango four years to find funding for a project close to her heart: researching ways to deliver dignified and more ...

"Please, please do it (cancer screening), if not for yourself, then for the next generation. We need to see the day when we end cancer." Those are the impassioned words of Charinus Johnson-Davis, who ...

ACCRA, Ghana & WASHINGTON--(BUSINESS WIRE)--Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch The African Cancer Atlas (TACA).

Pathways-to-Care Analysis of Non-Hodgkin Lymphoma in Ethiopia: A Mixed-Methods Study We conducted a descriptive analysis of GLOBOCAN 2022 estimates, summarizing age-standardized incidence rate (ASIR), ...

Language can give people the power to take an active part in their own healthcare, or it can create barriers. Effective communication raises awareness about diseases and is key to delivering good care ...

Rising rates appear concentrated in hormone receptor–positive disease, aligning with later age at first birth, fewer ...